- A new coronavirus vaccine candidate from Germany has entered human trials, and it might be ready for emergency use as soon as this fall.
- Vaccine candidate BNT162 was administered to volunteers in Germany, although healthy American adults will also be included in the trial.
- BioNTech is working with Pfizer on the drug that has the potential of preventing a COVID-19 infection.
- Visit BGR’s homepage for more stories.
Remdesivir may be the talk of the town right now because the anti-viral that was initially developed to treat Ebola will become standard care for COVID-19 patients, according to Dr. Anthony Fauci. The drug may not prevent deaths, but the preliminary findings of a massive study show it can reduce the recovery time in patients infected with the novel coronavirus. While COVID-19 complications can still appear, the drug may help patients recover faster and reduce their stays in hospitals. That could be of enormous help to both the patients and the medical centers treating large numbers of COVID-19 patients, especially once a second wave inevitably hits.
The anti-viral isn’t a “miracle cure,” but those drugs are also in the making. They’re vaccines, if you were wondering, and some 90 different candidates are already in the works. A brand new one from Germany just reached the human trials phase, and it could be available to millions of people as soon as this fall.
Today’s Top Deals
- Amazon has a special page full of face masks ready to ship out now
- Today’s top deals: Face masks and hand sanitizer in stock, $8 Anker wireless charger, $33 webcam, $49 Instant Pot, more
- Fire TV Stick 4K is just $25 if you know about this secret Amazon coupon
Trending Right Now:
- Best Buy’s big sale is packed with great deals today – here’s our top 10
- Waze is finally getting a navigation feature you’ve always wanted
- Can’t get your stimulus check info? Try this simple fix
This coronavirus vaccine might be just a few months away from release originally appeared on BGR.com on Thu, 30 Apr 2020 at 15:15:36 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report